Technology | 2019.07.18
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors
GERMANTOWN, Md., July 18, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, announced that Mary Ann Gray, Ph.D. has been appointed to the...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]rd-of-directors-300885589.html
